This article is more than 5 years old. Information may no longer be current.

Alcon board of directors elects new chairman

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

HUENENBERG, Switzerland — Alcon's board of directors has elected Daniel Vasella, MD, chairman of the board, the company announced in a press release.

Dr. Vasella, who has served on Alcon's board of directors since July 7, 2008, is also chairman of the board for Novartis, Alcon's majority shareholder.

Dr. Vasella will replace current Chairman Cary Rayment, who will remain seated on the board as its vice chairman, according to the release.

"I welcome Dr. Vasella into the chairman position and look forward to working with him on Alcon board matters," Kevin Buehler, Alcon's president and CEO, said in the release. "We are pleased that we will be able to continue to benefit from Mr. Rayment's extensive experience in the eye care industry in his role as vice chairman. I would also like to thank Cary for his numerous strategic contributions and for his guidance as chairman of the board for the last 5 years."